Adamas Pharmaceuticals, Inc is a drug manufacturers-specialty & generic business based in the US. Adamas Pharmaceuticals shares (ADMS) are listed on the NASDAQ and all prices are listed in US Dollars. Adamas Pharmaceuticals employs 138 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Adamas Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ADMS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Adamas Pharmaceuticals stock price (NASDAQ: ADMS)Use our graph to track the performance of ADMS stocks over time.
Adamas Pharmaceuticals shares at a glance
|Latest market close||$5.53|
|52-week range||$2.43 - $9.15|
|50-day moving average||$5.19|
|200-day moving average||$5.20|
|Wall St. target price||$8.79|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.25|
Buy Adamas Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Adamas Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Adamas Pharmaceuticals price performance over time
|1 week (2021-07-14)||N/A|
|1 month (2021-06-25)||5.74%|
|3 months (2021-04-21)||N/A|
|6 months (2021-01-21)||N/A|
|1 year (2020-07-21)||N/A|
|2 years (2019-07-21)||N/A|
|3 years (2018-07-21)||N/A|
|5 years (2016-07-21)||N/A|
Adamas Pharmaceuticals financials
|Revenue TTM||$79.3 million|
|Gross profit TTM||$72.4 million|
|Return on assets TTM||-14.11%|
|Return on equity TTM||0%|
|Market capitalisation||$232.5 million|
TTM: trailing 12 months
Shorting Adamas Pharmaceuticals shares
There are currently 2.1 million Adamas Pharmaceuticals shares held short by investors – that's known as Adamas Pharmaceuticals's "short interest". This figure is 1.1% up from 2.1 million last month.
There are a few different ways that this level of interest in shorting Adamas Pharmaceuticals shares can be evaluated.
Adamas Pharmaceuticals's "short interest ratio" (SIR)
Adamas Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Adamas Pharmaceuticals shares currently shorted divided by the average quantity of Adamas Pharmaceuticals shares traded daily (recently around 341742.58373206). Adamas Pharmaceuticals's SIR currently stands at 6.27. In other words for every 100,000 Adamas Pharmaceuticals shares traded daily on the market, roughly 6270 shares are currently held short.
However Adamas Pharmaceuticals's short interest can also be evaluated against the total number of Adamas Pharmaceuticals shares, or, against the total number of tradable Adamas Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Adamas Pharmaceuticals's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Adamas Pharmaceuticals shares in existence, roughly 50 shares are currently held short) or 0.0649% of the tradable shares (for every 100,000 tradable Adamas Pharmaceuticals shares, roughly 65 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Adamas Pharmaceuticals.
Find out more about how you can short Adamas Pharmaceuticals stock.
Adamas Pharmaceuticals share dividends
We're not expecting Adamas Pharmaceuticals to pay a dividend over the next 12 months.
Adamas Pharmaceuticals share price volatility
Over the last 12 months, Adamas Pharmaceuticals's shares have ranged in value from as little as $2.4301 up to $9.15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adamas Pharmaceuticals's is 2.6948. This would suggest that Adamas Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Adamas Pharmaceuticals overview
Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders in the United States. It offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications, as well as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing OFF episodes; and OSMOLEX ER, an extended release tablet to treat Parkinson's disease and drug-induced extrapyramidal reactions in adult patients. The company is also developing ADS-4101, which has completed two Phase 1b studies for treating partial onset seizures in patients with epilepsy. In addition, it offers NAMZARIC and NAMENDA XR, a memantine hydrochloride extended release and donepezil hydrochloride capsules for the treatment of moderate to severe dementia of an Alzheimer's type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc.
Stocks similar to Adamas Pharmaceuticals
Adamas Pharmaceuticals in the news
Adamas Announces Issuance of New Patents for GOCOVRI and ADS-4101
Adamas Announces Issuance of New Patents for GOCOVRI and ADS-4101
Adamas Pharmaceuticals announces issuance of new patents for Gocovri, ADS-4101
Frequently asked questionsWhat percentage of Adamas Pharmaceuticals is owned by insiders or institutions?
Currently 2.338% of Adamas Pharmaceuticals shares are held by insiders and 79.604% by institutions. How many people work for Adamas Pharmaceuticals?
Latest data suggests 138 work at Adamas Pharmaceuticals. When does the fiscal year end for Adamas Pharmaceuticals?
Adamas Pharmaceuticals's fiscal year ends in December. Where is Adamas Pharmaceuticals based?
Adamas Pharmaceuticals's address is: 1900 Powell Street, EmeryVille, CA, United States, 94608 What is Adamas Pharmaceuticals's ISIN number?
Adamas Pharmaceuticals's international securities identification number is: US00548A1060 What is Adamas Pharmaceuticals's CUSIP number?
Adamas Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00548A106
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert